Loading...
Loading...
In a report published Tuesday, Goldman Sachs analyst Bill Shope upgraded the rating on Emulex Corporation
ELX from Sell to Neutral, and reiterated the $6.00 price target.
In the report, Shope noted, “We are upgrading Emulex to Neutral from Sell and maintaining our 12-month price target of $6. Since we added Emulex to the Sell List on December 2, 2012, the stock has declined 17%, compared with a 15% increase in the S&P 500, and we no longer see enough incremental downside from current levels to warrant a Sell. Over the past 12 months, ELX is down 22% vs. the S&P 500 up 21%.”
Emulex Corporation closed on Monday at $6.11.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in